Orthofix Views 2022 As Inflection Point for Growth

Orthofix reported 4Q21 orthopedic sales of $125.1 million, +6.3% vs. 4Q20. For the full year, the company generated $464.5 million in orthopedic sales, +14.2 vs. 2020, and +1% compared to 2019.

The M6 artificial disc drove spine sales in the quarter and helped offset the impact from the decline in complex surgeries due to the omicron surge....

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us